Compound Detail
CHEMBL2106991
RALURIDINE Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
Basic Information
| ChEMBL ID | CHEMBL2106991 |
| Name | RALURIDINE |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | WKVDSZYIGHLONN-RRKCRQDMSA-N |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
6
Publications
3
Known Names
1
Indications
Molecular Properties
264.6
MW (Da)
-0.19
ALogP
5
HBA
2
HBD
84.3
PSA (Ų)
0.78
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Indications
HIV Infections
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32515595 | 10.1021/acs.jmedchem.0c00358 | Human immunodeficiency virus 1 | 3 |
| 2754700 | 10.1021/jm00128a013 | Human immunodeficiency virus type 1 reverse transcriptase | 2 |
| 2342078 | 10.1021/jm00168a046 | MT4 | 2 |
| 2754700 | 10.1021/jm00128a013 | MT4 | 1 |
| 2342078 | 10.1021/jm00168a046 | Human immunodeficiency virus 1 | 1 |
| 32515595 | 10.1021/acs.jmedchem.0c00358 | CCRF-CEM | 1 |
Data from ChEMBL 36 via Core Engine